Aradigm to Present at the Stifel Healthcare Conference 2014
Aradigm Corporation (Nasdaq:ARDM) (the “Company”) today announced that Igor Gonda, Aradigm’s President and Chief Executive Officer, will present an overview of the Company at the Stifel Healthcare Conference 2014 at the New York Palace Hotel in New York, New York on Tuesday, November 18, 2014 at 8:00 am Eastern time.
A live webcast of the presentation will be available at www.aradigm.com and a webcast replay will be archived on the Company’s website for 30 days.
Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases. Aradigm has product candidates addressing the treatment of non-CF BE, cystic fibrosis and prevention of respiratory and other diseases in tobacco smokers through smoking cessation. Aradigm is also developing Pulmaquin and a liposomal ciprofloxacin formulation as potential medications for patients with chronic lung infections with non-tuberculous mycobacteria (NTM), and for the prevention and treatment of high threat and bioterrorism infections, such as inhaled tularemia, pneumonic plague, Q fever and inhaled anthrax.
More information about Aradigm can be found at www.aradigm.com.
Aradigm and the Aradigm Logo are registered trademarks of Aradigm Corporation.
Sorry. No data so far.